Assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine-naloxone (Suboxone®) or methadone. (Source: Journal of Substance Abuse Treatment)
MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…
[Abstract unavailable]
Language: en… (Source: SafetyLit: All (Unduplicated))
[Abstract unavailable]
Language: en… (Source: SafetyLit: All (Unduplicated))
MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
No abstract available (Source: Survey of Anesthesiology)
No abstract available (Source: Survey of Anesthesiology)
MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
A conservative estimate suggests that over 10.2 million people are held in penal institutions throughout the world, which equates to a world prison population of 144 per 100,000 (Walmsley, 2013). Internationally, drug dependence is common amongst prison populations and many are dependent upon heroin. A systematic review of international prevalence studies of prison populations for drug dependence found prevalence rates for drug dependence to vary from 10% to 48% in male prisoners and 30% to 60% in female prisoners (Fazel et al., 2006). (Source: Drug and Alcohol Dependence)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
CONCLUSIONS: Generally, participants with lower baseline levels and greater decreases in craving and withdrawal during stabilization combined with slower craving and withdrawal rebound during buprenorphine taper remained opioid-free longer. This exploratory work expanded on the importance of monitoring craving and withdrawal during buprenorphine induction, stabilization, and taper. Future research may allow individually tailored and timely interventions to be developed to extend time-to-first opioid use.
PMID: 25282598 [PubMed – as supplied by publisher] (Source: Addictive Behaviors)
Abstract
SAMHSA Buprenorphine Meeting: Another Step Toward Lifting the Cap
Fraud Probe of Sober Homes Highlights Drug‐Test Scams
Bill Proposed to Provide Local Incentives to Treat Addiction
N.J. Bill Would Allow Outpatient Commitment for Addiction
California Certification: CAADAC + CAARR = CCAPP
NASADAD Issues Public Policy Statement Endorsing Naloxone
ASAM Revises Public Policy Statement on Naloxone
Methadone Patient on the Pain of Stigma
Coming up (Source: Alcoholism and Drug Abuse Weekly)
Abstract
SAMHSA Buprenorphine Meeting: Another Step Toward Lifting the Cap
Fraud Probe of Sober Homes Highlights Drug‐Test Scams
Bill Proposed to Provide Local Incentives to Treat Addiction
N.J. Bill Would Allow Outpatient Commitment for Addiction
California Certification: CAADAC + CAARR = CCAPP
NASADAD Issues Public Policy Statement Endorsing Naloxone
ASAM Revises Public Policy Statement on Naloxone
Methadone Patient on the Pain of Stigma
Coming up (Source: Alcoholism and Drug Abuse Weekly)
MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
We examined dose and other factors associated with pain intensity among patients initiating BUP/NX for opioid use disorder. (Source: Journal of Substance Abuse Treatment)